Cargando…
Treating Arterial Ageing in Patients with Diabetes: From Mechanisms to Effective Drugs
Diabetes mellitus is a major healthcare problem. It is not only characterized by hyperglycemia and chronic complications, but in longer lasting diabetes and a longer living population, it is also associated with accelerated arterial ageing, which importantly contributes to cardiovascular complicatio...
Autores principales: | Lunder, Mojca, Janić, Miodrag, Šabovič, Mišo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001638/ https://www.ncbi.nlm.nih.gov/pubmed/33801956 http://dx.doi.org/10.3390/ijms22062796 |
Ejemplares similares
-
A Low-Dose Combination of Fluvastatin and Valsartan: A New “Drug” and a New Approach for Decreasing the Arterial Age
por: Janić, Miodrag, et al.
Publicado: (2015) -
Arterial Stiffness and Cardiovascular Therapy
por: Janić, Miodrag, et al.
Publicado: (2014) -
Associations among different functional and structural arterial wall properties and their relations to traditional cardiovascular risk factors in healthy subjects: a cross-sectional study
por: Lunder, Mojca, et al.
Publicado: (2012) -
Expression of Longevity Genes Induced by a Low-Dose Fluvastatin and Valsartan Combination with the Potential to Prevent/Treat “Aging-Related Disorders”
por: Janić, Miodrag, et al.
Publicado: (2019) -
Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus
por: Lunder, Mojca, et al.
Publicado: (2018)